{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:21:58Z","timestamp":1788272518758,"version":"build-2803163510"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"6","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000082","name":"Division of Graduate Education","doi-asserted-by":"publisher","award":["DGE-1656466"],"award-info":[{"award-number":["DGE-1656466"]}],"id":[{"id":"10.13039\/100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1150755"],"award-info":[{"award-number":["OPP1150755"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1160404"],"award-info":[{"award-number":["OPP1160404"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE190100531"],"award-info":[{"award-number":["DE190100531"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP16"],"award-info":[{"award-number":["DP16"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP160102906"],"award-info":[{"award-number":["DP160102906"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clofazimine, a drug previously used to treat leprosy, has recently been identified as a potential new drug for the treatment for cryptosporidiosis: a diarrheal disease that contributes to 500\u2009000 infant deaths a year in developing countries. Rapid dissolution and local availability of the drug in the small intestine is considered key to the treatment of the infection. However, the commercially available clofazimine formulation (Lamprene) is not well-suited to pediatric use, and therefore reformulation of clofazimine is desirable. Development of clofazimine nanoparticles through the process of flash nanoprecipitation (FNP) has been previously shown to provide fast and improved drug dissolution rates compared to clofazimine crystals and Lamprene. In this study, we investigate the effects of milk-based formulations (as possible pediatric-friendly vehicles) on the in vitro solubilization of clofazimine formulated as either lecithin- or zein\/casein-stabilized nanoparticles. Milk and infant formula were used as the lipid vehicles, and time-resolved synchrotron X-ray scattering was used to monitor the presence of crystalline clofazimine in suspension during in vitro lipolysis under intestinal conditions. The study confirmed faster dissolution of clofazimine from all the FNP formulations after the digestion of infant formula was initiated, and a reduced quantity of fat was required to achieve similar levels of drug solubilization compared to the reference drug material and the commercial formulation. These attributes highlight not only the potential benefits of the FNP approach to prepare drug particles but also the fact that enhanced dissolution rates can be complemented by considering the amount of co-administered fat in lipid-based formulations to drive the solubilization of poorly soluble drugs.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.9b00276","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T15:46:37Z","timestamp":1556639197000},"page":"2755-2765","source":"Crossref","is-referenced-by-count":26,"title":["Solid-State Behavior and Solubilization of Flash Nanoprecipitated\nClofazimine Particles during the Dispersion and Digestion of Milk-Based\nFormulations"],"prefix":"10.1021","volume":"16","author":[{"given":"Malinda","family":"Salim","sequence":"first","affiliation":[{"name":"Monash University (Parkville Campus) , , 381 Royal Parade , , ,","place":["Parkville, Victoria, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Monash University (Parkville Campus) , , 381 Royal Parade , , ,","place":["Parkville, Victoria, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-853X","authenticated-orcid":true,"given":"Andrew J.","family":"Clulow","sequence":"additional","affiliation":[{"name":"Monash University (Parkville Campus) , , 381 Royal Parade , , ,","place":["Parkville, Victoria, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Princeton University , , , ,","place":["Princeton, New Jersey, United States, 08540"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt D.","family":"Ristroph","sequence":"additional","affiliation":[{"name":"Princeton University , , , ,","place":["Princeton, New Jersey, United States, 08540"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[{"name":"Princeton University , , , ,","place":["Princeton, New Jersey, United States, 08540"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-1259","authenticated-orcid":true,"given":"Simon A.","family":"McManus","sequence":"additional","affiliation":[{"name":"Princeton University , , , ,","place":["Princeton, New Jersey, United States, 08540"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hawley","sequence":"additional","affiliation":[{"name":"SAXS\/WAXS Beamline, Australian Synchrotron, ANSTO , 800 Blackburn Rd , , ,","place":["Clayton, Victoria, Australia, 3169"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-0097","authenticated-orcid":true,"given":"Robert K.","family":"Prud\u2019homme","sequence":"additional","affiliation":[{"name":"Princeton University , , , ,","place":["Princeton, New Jersey, United States, 08540"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-590X","authenticated-orcid":true,"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[{"name":"Monash University (Parkville Campus) , , 381 Royal Parade , , ,","place":["Parkville, Victoria, Australia, 3052"]},{"name":"Monash University (Parkville Campus) , , 381 Royal Parade , , ,","place":["Parkville, Victoria, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"2026090110005422500_cit1","first-page":"75","article-title":"Clofazimine","volume-title":"Analytical Profiles of Drug\nSubstances and Excipients","author":"O\u2019Driscoll","year":"1992"},{"key":"2026090110005422500_cit2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jac\/dkr444","article-title":"Clofazimine: current status and future prospects","volume":"67","author":"Cholo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"2026090110005422500_cit3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005373","article-title":"A high-throughput\nphenotypic screen identifies clofazimine as a potential treatment\nfor cryptosporidiosis","volume":"11","author":"Love","year":"2017","journal-title":"PLoS Neglected Trop.\nDis."},{"key":"2026090110005422500_cit4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/mr.47.1.84-96.1983","article-title":"Cryptosporidiosis\nin animals and humans","volume":"47","author":"Tzipori","year":"1983","journal-title":"Microbiol. Rev."},{"key":"2026090110005422500_cit5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/591539","article-title":"Cryptosporidiosis in\nChildren in Sub-Saharan Africa:\nA Lingering Challenge","volume":"47","author":"Mor","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"2026090110005422500_cit6","unstructured":"WHO.\n          .  Diarrhoeal disease, 2017."},{"key":"2026090110005422500_cit7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: A New Thiazolide Antiparasitic\nAgent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"2026090110005422500_cit8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered\ndrugs on the World Health Organization Model list of Essential Medicines\naccording to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2026090110005422500_cit9","doi-asserted-by":"crossref","DOI":"10.1201\/b15445","volume-title":"Oral Drug Absorption:\nPrediction and Assessment","author":"Dressman","year":"2000"},{"key":"2026090110005422500_cit10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0378-5173(03)00236-9","article-title":"Efficacy of\nclofazimine-modified\ncyclodextrin against Mycobacterium avium complex in human macrophages","volume":"260","author":"Salem","year":"2003","journal-title":"Int. J. Pharm."},{"key":"2026090110005422500_cit11","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1021\/cg301463z","article-title":"Clofazimine Mesylate:\nA High Solubility Stable Salt","volume":"12","author":"Bolla","year":"2012","journal-title":"Cryst. Growth\nDes."},{"key":"2026090110005422500_cit12","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1021\/acsomega.7b01454","article-title":"Role of\nBiorelevant Dissolution Media in the Selection of Optimal Salt Forms\nof Oral Drugs: Maximizing the Gastrointestinal Solubility and in Vitro\nActivity of the Antimicrobial Molecule, Clofazimine","volume":"2","author":"Bannigan","year":"2017","journal-title":"ACS Omega"},{"key":"2026090110005422500_cit13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejps.2017.11.004","article-title":"Development\nof PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment\nof formulation variables and intestinal permeability","volume":"112","author":"Chaves","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"2026090110005422500_cit14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2217\/nnm-2016-0364","article-title":"Clofazimine encapsulation in nanoporous\nsilica particles for the oral treatment of antibiotic-resistant Mycobacterium\ntuberculosis infections","volume":"12","author":"Valetti","year":"2017","journal-title":"Nanomedicine"},{"key":"2026090110005422500_cit15","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/aac.40.8.1893","article-title":"Liposome\nencapsulation of clofazimine reduces toxicity in vitro and in vivo\nand improves therapeutic efficacy in the beige mouse model of disseminated\nMycobacterium avium-M. intracellulare complex infection","volume":"40","author":"Mehta","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090110005422500_cit16","first-page":"1450","article-title":"Design and evaluation of lipid based drug delivery\nsystem of clofazimine for leprosy treatment","volume":"5","author":"Saxena","year":"2016","journal-title":"World J. Pharm. Res."},{"key":"2026090110005422500_cit17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jac\/45.1.77","article-title":"Preparation of a clofazimine nanosuspension\nfor intravenous use and evaluation of its therapeutic efficacy in\nmurine Mycobacterium avium infection","volume":"45","author":"Peters","year":"2000","journal-title":"J. Antimicrob.\nChemother."},{"key":"2026090110005422500_cit18","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1021\/acs.molpharmaceut.7b00521","article-title":"Design\nand Solidification of Fast-Releasing Clofazimine Nanoparticles for\nTreatment of Cryptosporidiosis","volume":"14","author":"Zhang","year":"2017","journal-title":"Mol. Pharmaceutics"},{"key":"2026090110005422500_cit19","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1021\/acsanm.8b00234","article-title":"Rapid Recovery\nof Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability\nas Anti-Cryptosporidium Therapy","volume":"1","author":"Feng","year":"2018","journal-title":"ACS Appl. Nano\nMater."},{"key":"2026090110005422500_cit20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","article-title":"Nanoprecipitation\nprocess: From encapsulation\nto drug delivery","volume":"532","author":"Rivas","year":"2017","journal-title":"Int. J. Pharm."},{"key":"2026090110005422500_cit21","doi-asserted-by":"publisher","first-page":"118302","DOI":"10.1103\/physrevlett.91.118302","article-title":"Mechanism for Rapid\nSelf-Assembly of Block Copolymer\nNanoparticles","volume":"91","author":"Johnson","year":"2003","journal-title":"Phys. Rev. Lett."},{"key":"2026090110005422500_cit22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.10.069","article-title":"Revisiting dispersible milk-drug tablets as a solid\nlipid formulation in the context of digestion","volume":"554","author":"Binte Abu Bakar","year":"2019","journal-title":"Int. J. Pharm."},{"key":"2026090110005422500_cit23","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/acs.molpharmaceut.8b00541","article-title":"Interactions of artefenomel (OZ-439)\nwith milk during digestion: insights into digestion-driven solubilization\nand polymorphic transformations","volume":"15","author":"Salim","year":"2018","journal-title":"Mol. Pharm."},{"key":"2026090110005422500_cit24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.chemphyslip.2017.10.009","article-title":"A closer look at\nthe behaviour of milk lipids during digestion","volume":"211","author":"Clulow","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"2026090110005422500_cit25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2018.10.027","article-title":"The impact of digestion\nis essential to the understanding\nof milk as a drug delivery system for poorly water soluble drugs","volume":"292","author":"Boyd","year":"2018","journal-title":"J. Controlled Release"},{"key":"2026090110005422500_cit26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijpharm.2015.05.015","article-title":"Milk as a medium for\npediatric formulations: Experimental\nfindings and regulatory aspects","volume":"492","author":"Soulele","year":"2015","journal-title":"Int. J. Pharm."},{"key":"2026090110005422500_cit27","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/acs.molpharmaceut.8b00541","article-title":"Interactions of Artefenomel (OZ439)\nwith Milk during Digestion: Insights into Digestion-Driven Solubilization\nand Polymorphic Transformations","volume":"15","author":"Salim","year":"2018","journal-title":"Mol. Pharmaceutics"},{"key":"2026090110005422500_cit28","first-page":"9","article-title":"Pharmacokinetics\nof clofazimine in healthy volunteers","volume":"55","author":"Schaad-Lanyi","year":"1987","journal-title":"Int. J.\nLepr. Other Mycobact. Dis."},{"key":"2026090110005422500_cit29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tube.2004.04.001","article-title":"Pharmacokinetics\nand relative bioavailability of clofazimine\nin relation to food, orange juice and antacid","volume":"84","author":"Nix","year":"2004","journal-title":"Tuberculosis"},{"key":"2026090110005422500_cit30","unstructured":"WHO.\n          .  WHO Model Prescribing Information: Drugs\nUsed in Mycobacterial\nDiseases, 1991."},{"key":"2026090110005422500_cit31","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1021\/acs.cgd.6b01411","article-title":"Investigation into the Solid and Solution Properties\nof Known and Novel Polymorphs of the Antimicrobial Molecule Clofazimine","volume":"16","author":"Bannigan","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"2026090110005422500_cit32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1083\/jcb.89.2.292","article-title":"Subcellular compartmentalization\nof maize storage proteins in Xenopus oocytes injected with zein messenger\nRNAs","volume":"89","author":"Hurkman","year":"1981","journal-title":"J. Cell Biol."},{"key":"2026090110005422500_cit33","doi-asserted-by":"publisher","DOI":"10.3791\/58757","article-title":"Flash NanoPrecipitation\nfor the Encapsulation of Hydrophobic and Hydrophilic Compounds in\nPolymeric Nanoparticles","volume":"143","author":"Markwalter","year":"2019","journal-title":"J. Visualized Exp."},{"key":"2026090110005422500_cit34","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1021\/acs.molpharmaceut.6b00594","article-title":"Lipid-Based Formulations Can Enable\nthe Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate\nin an Amorphous-Salt Form During In Vitro Digestion","volume":"13","author":"Khan","year":"2016","journal-title":"Mol. Pharmaceutics"},{"key":"2026090110005422500_cit35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejpb.2019.02.001","article-title":"A review of GI conditions\ncritical to oral drug absorption in malnourished children","volume":"137","author":"Freerks","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2026090110005422500_cit36","first-page":"549","article-title":"A rapid and sensitive high performance\nliquid chromatographic\nanalysis of clofazimine in plasma","volume":"60","author":"Krishnan","year":"1992","journal-title":"Int J Lepr\nOther Mycobact Dis"},{"key":"2026090110005422500_cit37","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1021\/acs.molpharmaceut.5b00032","article-title":"Chemical Analysis of Drug Biocrystals:\nA Role for Counterion Transport Pathways in Intracellular Drug Disposition","volume":"12","author":"Keswani","year":"2015","journal-title":"Mol. Pharmaceutics"},{"key":"2026090110005422500_cit38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/(sici)1520-6017(200004)89:4&lt;457::aid-jps3&gt;3.0.co;2-g","article-title":"Energy\/Temperature Diagram and Compression\nBehavior of the Polymorphs of D-Mannitol","volume":"89","author":"Burger","year":"2000","journal-title":"J.\nPharm. Sci."},{"key":"2026090110005422500_cit39","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1021\/mp3003072","article-title":"Structural\nElucidation of Rapid Solution-Mediated Phase Transitions in Pharmaceutical\nSolids Using in Situ Synchrotron SAXS\/WAXS","volume":"9","author":"Boetker","year":"2012","journal-title":"Mol. Pharmaceutics"},{"key":"2026090110005422500_cit40","volume-title":"X-Ray Diffraction: In\nCrystals, Imperfect Crystals, and Amorphous Bodies","author":"Guinier","year":"1963"},{"key":"2026090110005422500_cit41","unstructured":"FDA.\n          .  Prescribing Information for Lamprene\u00ae; 2016."},{"key":"2026090110005422500_cit42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1515\/zpch-1897-2233","article-title":"Studien u\u0308ber\ndie Bildung und Umwandlung fester Ko\u0308rper","volume":"22U","author":"Ostwald","year":"1897","journal-title":"Z. Phys. Chem."},{"key":"2026090110005422500_cit43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejps.2004.08.003","article-title":"Solubilisation of poorly water-soluble\ndrugs during\nin vitro lipolysis of medium- and long-chain triacylglycerols","volume":"23","author":"Christensen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"2026090110005422500_cit44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/jps.20039","article-title":"Use of\nin vitro\nlipid digestion data to explain the in vivo performance of triglyceride-based\noral lipid formulations of poorly water-soluble drugs: Studies with\nhalofantrine","volume":"93","author":"Porter","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"2026090110005422500_cit45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0378-5173(94)90142-2","article-title":"The effect of mixed\nmicellar systems, bile salt\/fatty acids, on the solubility and intestinal\nabsorption of clofazimine (B663) in the anaesthetised rat","volume":"109","author":"O\u2019Reilly","year":"1994","journal-title":"Int. J. Pharm."},{"key":"2026090110005422500_cit46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based\nformulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv. Drug Delivery Rev."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.9b00276","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/6\/2755\/67453415\/acs.molpharmaceut.9b00276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/6\/2755\/67453415\/acs.molpharmaceut.9b00276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:01:01Z","timestamp":1788271261000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/16\/6\/2755\/509580\/Solid-State-Behavior-and-Solubilization-of-Flash"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,30]]},"published-print":{"date-parts":[[2019,6,3]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00276","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]}}}